论文部分内容阅读
最新的早期研究结果证实,一种新型抗HIV制剂能够通过对两个关键的HIV复合受体CCR5和CXCR4的双重拮抗而阻断HIV的复制,该结果令艾滋病研
The latest early findings confirm that a new anti-HIV agent blocks HIV replication through dual antagonism of the two key HIV complex receptors CCR5 and CXCR4, which has led to the development of AIDS research